Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Hyperglycemia 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma 2Leukemia 2Leukemia, Myeloid, Acute 1Insulin Resistance 1Hyperphagia 1Diabetes Mellitus, Type 2 1Congenital Abnormalities 1Burkitt Lymphoma 1

Interventions

relacorilant 5Pioglitazone 4Metformin 4Sitagliptin Phosphate 3Resistance Training 3Dipeptidyl-Peptidase IV Inhibitors 3saxagliptin 2Vildagliptin 2Sulfonylurea Compounds 2Rosiglitazone 2Nutritional Status 2Blood Specimen Collection 2voglibose 1somapacitan 1semaglutide 1repaglinide 1pembrolizumab 1miglitol 1metahexamide 1meglitinide 1mazdutide 1glymidine 1glisoxepide 1gliquidone 1glimepiride 1glibornuride 1empagliflozin 1dapagliflozin 1alogliptin 1Urine Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diabetes Mellitus, Type 2 × Insulin Glargine × Clear all
NCT02012465 2018-05-07

Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients

Washington University School of Medicine

Phase EARLY_PHASE1 Completed
15 enrolled
Lymphoid

Diabetes Mellitus, Type 2, Hyperglycemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡